Topic
Biologic drugs clinically equivalent to an approved reference biologic, typically sold at lower cost, similar in role to generics for small-molecule drugs.
Korean exports of seven food, beauty and bio products reached $15.59 billion in January-August, 4.2 times 2016 against 2.2 times for all exports. On the chamber's figures the U.S. and Europe now take 52% of it, up from 19%.
Reality
Celltrion reported preliminary third-quarter operating profit of 510 billion won, up 69.2% from a year earlier, on revenue of 1.5 trillion won. It is the third straight quarter above the company's own target, and Celltrion credits next-generation biosimilars and lower costs.
Reality
South Korea's biopharma exports rose 15.8% to a record $6.6 billion in the first nine months, led by Europe, the drug safety ministry said. With US shipments down 23.7%, Seoul Economic Daily reported, the record rests on European contract manufacturing and biosimilar demand.
Perspective Coverage
3 publishersReality
Lotte Biologics will make drug substance for several Alvotech antibody biosimilars at its 40,000-liter plant in Syracuse, New York. Alvotech's CEO said its network now covers a decade of pipeline demand, so more work for Lotte depends on how many Alvotech products launch.
Reality
Morgan Health led a Series E of more than $125m that values Thyme Care above $2bn, roughly double its mark from under a year ago. The payers on the cap table are underwriting a savings number the company validated itself.
Perspective Coverage
4 publishersReality